Lawrence P. Andrews

2.7k citations
14 papers · 1.9k indexed · 3 hit papers · h-index 11
Topics
Cancer Immunotherapy and Biomarkers (9 papers)Immune Cell Function and Interaction (7 papers)CAR-T cell therapy research (6 papers)

In The Last Decade

Lawrence P. Andrews

13 papers receiving 1.9k citations

Hit Papers

LAG3 (CD223) as a cancer immunotherapy target2017202620202023201720192024200400600

Peers

Lawrence P. Andrews
Comparison fields: 5 of 88
  • Oncology 1.3k
  • Immunology 1.1k
  • Molecular Biology 392
  • Pulmonary and Respiratory Medicine 244
  • Cancer Research 159
Replace Hugo Arasanz with:
Hugo Arasanz Spain
Jesse M. Zaretsky United States
Sreya Bagchi United States
Viktor Fleming Germany
Grégory Verdeil Switzerland
Cara Haymaker United States
Dario Sangiolo Italy
Serena S. Kwek United States
Kim C. Ohaegbulam United States
Kosaku Mimura Japan
Lawrence P. Andrews relative to Hugo Arasanz Spain Hugo Arasanz's profile →
Citations per field
00.5×10×20×30×
Hugo Arasanz · 1×
Citations per year

Countries citing papers authored by Lawrence P. Andrews

Since Specialization
Citations

This map shows the geographic impact of Lawrence P. Andrews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence P. Andrews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence P. Andrews more than expected).

Fields of papers citing papers by Lawrence P. Andrews

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence P. Andrews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence P. Andrews. The network helps show where Lawrence P. Andrews may publish in the future.

Co-authorship network of co-authors of Lawrence P. Andrews

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence P. Andrews. A scholar is included among the top collaborators of Lawrence P. Andrews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence P. Andrews. Lawrence P. Andrews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1
LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunitybreakdown →
110
2 71
3 9
4 59
5
Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backupsbreakdown →
401
6 84
7 9
8 44
9
LAG3 (CD223) as a cancer immunotherapy targetbreakdown →
684
10 243
11 119
12 0
13 77
14 18

About Lawrence P. Andrews

Lawrence P. Andrews is a scholar working on Immunology, Oncology and Neurology, having authored 14 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Immune Cell Function and Interaction (7 papers) and CAR-T cell therapy research (6 papers). The work is most often cited by research in Immunology (1.1k citations), Oncology (1.3k citations) and Cancer Research (159 citations). Lawrence P. Andrews has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Dario A.A. Vignali, Hiroshi Yano, Charles G. Drake, Ariel E. Marciscano, Creg J. Workman, Meghan E. Turnis, Greg M. Delgoffe, Andrea L. Szymczak-Workman, Deepali V. Sawant and Peter Vogel. Their work appears in journals such as Cell, Immunity and Nature Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026